Single and combination treatment of Toxoplasma gondii infections with a bumped kinase inhibitor and artemisone in vitro and with artemiside in experimentally infected mice
Carling Schlange, Joachim Müller, Dennis Imhof, Kai Pascal Alexander Hänggeli, Ghalia Boubaker, Luis-Miguel Ortega-Mora, Ho Ning Wong, Richard K. Haynes, Wesley C. Van Voorhis, Andrew Hemphill · 2023
Read Single and combination treatment of Toxoplasma gondii infections with a bumped kinase inhibitor and artemisone in vitro and with artemiside in experimentally infected mice by Carling Schlange, Joachim Müller, Dennis Imhof, Kai Pascal Alexander Hänggeli, Ghalia Boubaker, Luis-Miguel Ortega-Mora, Ho Ning Wong, Richard K. Haynes, Wesley C. Van Voorhis, Andrew Hemphill (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11585351.txt.
Description
Carling Schlange and co-authors test two drugs, alone and together, against the parasite Toxoplasma gondii, in a 2023 study. The parasite infects many people and is dangerous for those with weak immune systems and for unborn babies.
In infected human cells, the pair worked better together than either drug alone at strong doses. Under the microscope, parasites treated with both showed damage patterns neither drug caused by itself. In infected mice the story changed: one drug alone cut parasite counts in the brain, and adding the second brought no extra gain. The second drug alone did nothing measurable. It also disrupted pregnancy, blocking one planned test.
Catalog record
| CREATOR | Carling Schlange, Joachim Müller, Dennis Imhof, Kai Pascal Alexander Hänggeli, Ghalia Boubaker, Luis-Miguel Ortega-Mora, Ho Ning Wong, Richard K. Haynes, Wesley C. Van Voorhis, Andrew Hemphill |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |